Ayala Pharmaceuticals Inc (ADXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 10-2022 | 09-2022 | 07-2022 | 06-2022 | 04-2022 | |
| Sales | -549 | 91 | 0 | 38 | 250 |
| Cost of Goods | N/A | 91 | N/A | 38 | N/A |
| Gross Profit | -90 | N/A | N/A | N/A | 250 |
| Operating Expenses | -1,287 | 10,171 | 7,291 | 7,890 | 3,252 |
| Operating Income | -4,853 | -10,080 | -7,291 | -7,852 | -3,002 |
| Other Income | 262 | 1 | 328 | -42 | 612 |
| Pre-tax Income | -4,591 | -10,079 | -6,963 | -7,894 | -2,390 |
| Income Tax | -295 | 106 | N/A | 214 | 50 |
| Net Income Continuous | -4,591 | -10,185 | -6,963 | -8,108 | -2,440 |
| Net Income | $-4,591 | $-10,185 | $-6,963 | $-8,108 | $-2,440 |
| EPS Basic Total Ops | -2.73 | -3.51 | -3.83 | -2.83 | -1.90 |
| EPS Basic Continuous Ops | -2.84 | -3.51 | -3.83 | -2.83 | -1.34 |
| EPS Diluted Total Ops | -2.73 | -3.51 | -3.83 | -2.83 | -1.90 |
| EPS Diluted Continuous Ops | 0.75 | -3.51 | -3.83 | -2.83 | -1.34 |
| EPS Diluted Before Non-Recurring Items | N/A | N/A | N/A | -3.83 | N/A |
| EBITDA(a) | $1,090 | $-10,040 | $-7,251 | $-7,970 | $-3,120 |